GSE65634 resveratrol fibroblast 7 v 3 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE65634_resveratrol_fibroblast_7_v_3_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE65634_resveratrol_fibroblast_7_v_3_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE65634_resveratrol_fibroblast_7_v_3_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE65634_resveratrol_fibroblast_7_v_3_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

dehydrogenase/reductase X-linked

Gene

HLA complex group 11

Gene

long intergenic non-protein coding RNA 1128

Gene

HOX transcript antisense RNA

Gene

long intergenic non-protein coding RNA 857

Gene

uncharacterized LOC124904434

Gene

TTC28 antisense RNA 1

Gene

ALOX12 antisense RNA 1

Gene

ZMIZ1 antisense RNA 1

Gene

MRPL23 antisense RNA 1

  • Gene

    dehydrogenase/reductase X-linked


  • Gene

    HLA complex group 11


  • Gene

    long intergenic non-protein coding RNA 1128


  • Gene

    HOX transcript antisense RNA


  • Gene

    long intergenic non-protein coding RNA 857


  • Gene

    uncharacterized LOC124904434


  • Gene

    TTC28 antisense RNA 1


  • Gene

    ALOX12 antisense RNA 1


  • Gene

    ZMIZ1 antisense RNA 1


  • Gene

    MRPL23 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.